| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | — | +177.8% |
| Cost of Revenue | $598K | — | -87.3% |
| R&D Expense | $15.4M | — | -16.5% |
| SG&A Expense | $7.0M | — | -53.6% |
| Operating Income | -$20.3M | — | -115.0% |
| Pre-tax Income | -$20.2M | — | -6505.4% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$20.2M | — | -7277.7% |
| EPS (Basic) | -$0.16 | — | -500.0% |
| EPS (Diluted) | -$0.16 | — | -500.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $216.9M | -0.1% | +438.8% |
| Accounts Receivable | $1.1M | +94.2% | +118.7% |
| Inventory | $4.6M | +3.5% | +50.1% |
| Current Assets | $242.0M | -7.5% | +152.9% |
| Total Assets | $270.3M | -6.9% | +107.9% |
| Current Liabilities | $23.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.6M | — | -58.5% |
| Investing Cash Flow | $19.3M | — | +713.5% |
| Financing Cash Flow | $2K | — | — |
| -8.2% |
| Long-term Debt | $75.0M | +0.0% | +0.0% |
| Total Liabilities | $101.8M | -2.2% | -4.9% |
| Stockholders' Equity | $168.4M | -9.6% | +634.2% |